🏢 官网IRPRGOCodex · 实盘不做把握 8/10
北京时间·🕒 发布 20:30:00(美东 08:30)·⟳ 抓取 20:31:34 +1m34s·⚡ 决策 07-30 20:32:46 +1m12s·89.1 天前
Perrigo宣布每股0.29美元例行季度股息
这是一则公司例行季度分红公告，未披露增派、特别分红、回购或资本返还政策变化。
📄 原文PRGO↗ 原文
Perrigo Announces Quarterly Dividend
DUBLIN, July 30, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care produc…
不做 Perrigo Company plc（PRGO.US）
例行季度分红公告，未披露增派、特别分红或业绩/现金流新信息，缺乏短线正向或负向交易edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-30 · 扩散 low · price-in 风险 medium ↗
关键理由
- 这是一则公司例行季度分红公告，未披露增派、特别分红、回购或资本返还政策变化。
主要风险
- 若后续披露分红政策发生变化或与业绩指引绑定，需要按新事件重新判断。
原文全文
展开原文 · 2,349 字
DUBLIN, July 30, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that its Board of Directors has approved a quarterly dividend of $0.29 per share, or $1.16 per share on an annualized basis. The cash dividend is payable on September 15, 2026, to shareholders of record on August 28, 2026.
About Perrigo
Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.
For more information, visit www.perrigo.com.
Forward-Looking Statements
This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025.
Perrigo Contacts
Eric Jacobson, Vice President, Global Investor Relations
eric.jacobson@perrigo.com
Nick Gallagher, Associate Director, Global Investor Relations
nicholas.gallagher@perrigo.com
SOURCE Perrigo Company plc
About Perrigo
Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.
For more information, visit www.perrigo.com.
Forward-Looking Statements
This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025.
Perrigo Contacts
Eric Jacobson, Vice President, Global Investor Relations
eric.jacobson@perrigo.com
Nick Gallagher, Associate Director, Global Investor Relations
nicholas.gallagher@perrigo.com
SOURCE Perrigo Company plc
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。